Results - Fix Bdsthanhhoavn


VANCOUVER, BC, Nov. 16, 2022 /CNW/ – Datable Technology Corporation (TSXV: DAC) (OTC Pink: TTMZF) (the “Company” or “Datable” or “DTC”), the developer of a proprietary, SaaS-based Consumer Lifecycle and Data Management Platform called PLATFORM3, is pleased to announce its financial results for the quarter ended September 30, 2022 (“Q3 2022”). For the periods three … Read more

InspireSemi Announces Third Quarter 2022 Business Update and Financial Results Conference Call

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Breadcrumb Trail Links GlobeNewswire Author of the article: Article content Call Scheduled for Tuesday, November 22, 2022 at 10:00 am … Read more

BerGenBio reports third quarter 2022 financial results and provides business update

– Randomized first patient in the Phase 2b EU-SolidAct platform for hospitalized COVID-19 patients –– Initiated Phase 1b/2a trial in 1st line NSCLC patients harboring STK11 mutations –– Strengthened financial position with support from largest shareholder – BERGEN, Norway, Nov. 15, 2022 /PRNewswire/ — BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase … Read more

The INX Digital Company Reports Third Quarter 2022 Update and Financial Results

TORONTO, Nov 14, 2022 /CNW/ — The INX Digital Company, Inc. (NEO: INXD, OTCQB: INXDF, INXATS: INX) (the “Company” or “INX”), the owner of digital asset trading platforms, a broker-dealer, and an inter-dealer broker (through its subsidiaries), announced financial results for its third quarter ended September 30, 2022. INX MAKES HISTORY WITH THE LISTING OF … Read more

Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results

NEW YORK–(BUSINESS WIRE)–Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today provided a business update for the Company and presented financial results for the three and nine months ended September 30, 2022. Conference Call and Webcast A … Read more

Vaccinex Reports Third Quarter 2022 Results and Provides Corporate Update

Continued Progress in Pepinemab Oncology and Neurology Clinical Programs Promising initial responses in Phase 1b/2 open-label KEYNOTE B84 study of pepinemab with KEYTRUDA® in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patient enrollment continues in the Phase 1b/2 KEYNOTE B84 oncology and Phase 1/2a SIGNAL-AD Alzheimer’s studies Several posters and presentations expected at November Medical … Read more

Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update

~ In September 2022, FDA Approved PEDMARK®, the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic Tumors ~ ~ Initiated U.S. Commercial Launch of PEDMARK® in October 2022 ~ ~ Closed $25 Million in Funding from Petrichor to Support the U.S. Commercialization … Read more

Exro Technologies Provides Operational Update and Announces Third Quarter 2022 Financial Results

Exro remains on schedule for key deliverables and milestones in Q4 2022, including: prototype e-axle delivery to Linamar, pilots to both Vicinity and SEA Electric, ISO certification by year-end First deliveries of Exro’s Coil DriverTM for series production remain on schedule to begin in Q3 2023 Exro’s Cell DriverTM on schedule to complete UL certification … Read more

Electra Reports Q3 Results and Provides Update on Cobalt Refinery Project and Black Mass Recycling Demonstration

TORONTO–(BUSINESS WIRE)–Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today announced the filing of its financial results for the third quarter ended September 30, 2022, and provided an update on the commissioning of its cobalt refinery and launch of its black mass recycling demonstration plant. All amounts are in Canadian currency … Read more

Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update

MARINA DEL REY, Calif., Nov. 9, 2022 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its third quarter 2022 and provided a corporate update.   Third Quarter 2022 and Recent Developments: SWARM-P.a. enrolling … Read more